21st Dec 2012 10:38
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
| 1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Clinigen Group PLC | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | X | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to thenotification obligation: iii | Grandeur Peak Global Advisors, LLC | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv | FIT, Grandeur Peak Global Opportunities Fund FIT, Grandeur Peak International Opportunities Fund Grandeur Peak Global Opportunities, LP | ||||
| 5. Date of the transaction and date onwhich the threshold is crossed orreached: v | December 19, 2012 | ||||
| 6. Date on which issuer notified: | December 20, 2012 | ||||
| 7. Threshold(s) that is/are crossed orreached: vi, vii | 4% | ||||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
| NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| GB00B89J2419 | 3,293,000 | 3,293,000 | 3,368,000 | 3,368,000 | 4.08% | |||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to 
 | % of voting rights xix, xx 
 | |||||||||||
| 
 
 | Nominal | Delta | ||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 3,368,000 | 4.08% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
| 
 As of December 19, 2012, our total position is 4.08%. Specifically: FIT, Grandeur Peak Global Opportunities Fund owns 1,615,000 shares or 2.0% FIT, Grandeur Peak International Opportunities Fund owns 1,259,000 shares or 1.5% Grandeur Peak Global Opportunities, LP owns 494,000 shares or 0.6% | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | Grandeur Peak Global Advisors, LLC | |
| 11. Number of voting rights proxy holder will ceaseto hold: | 0 | |
| 12. Date on which proxy holder will cease to holdvoting rights: | Not applicable | |
| 13. Additional information: | Grandeur Peak Global Advisors 136 South Main Street, Suite 720 Salt Lake City, UT 84101 | |
| 14. Contact name: | Amy Hone, Vice President Trading & Operations | |
| 15. Contact telephone number: | 801-384-0007 | |
| Note: Annex should only be submitted to the FSA not the issuer | |
| Annex: Notification of major interests in share | |
| A: Identity of the persons or legal entity subject to the notification obligation | |
| Full name (including legal form of legal entities) 
 | |
| Contact address (registered office for legal entities) 
 | |
| Phone number & email 
 | |
| Other useful information (at least legal representative for legal persons) 
 | |
| B: Identity of the notifier, if applicable | |
| Full name 
 | |
| Contact address 
 | |
| Phone number & email 
 | |
| Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) | |
| C: Additional information | |
| For notes on how to complete form TR-1 please see the FSA website. | |
Related Shares:
CLIN.L